LIFDOTCPharmaceutical PreparationsFiscal year ends December 31

LFTD PARTNERS INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 14, 2026

$0.10+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $1.48M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Mar 31, 2026

Lftd Partners reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Lftd Partners's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Lftd Partners's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LIFD.

Gross margin23.5% · median 57.3%

Operating margin-9.0% · median -7.6%

Net margin-77.7% · median -11.1%

Company	Revenue	Growth
INBP	$43.87M	-19.3%
LIFD	$36.96M	–
ZOMDF	$36.88M	+30.1%
ETST	$35.96M	+8.0%
CVSI	$12.74M	-14.9%
BHST	–	–

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 100
Auditor: Fruci & Associates II, PLLC
SEC CIK: 1391135

Advertisement
300 × 250